drugset / Trial / NCT03637400

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

NCT03637400

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare how well two different antibiotics, doxycycline (DOXY) and trimethoprim/sulfamethoxazole (TMP/SMX), work at curing uncomplicated skin and soft tissue infection (uSSTI) such as 1.Boils (pus in the skin, also known as abscesses and furuncles) or 2. Infections that appear only on the skin surface (called cellulitis and erysipelas) that have pus.

Timeline

Start
2018-11-26
Primary completion
2024-02-12
Completion
2025-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline hyclate Small molecule 2.2 mg/kg
Subject Doxycycline hyclate Small molecule 100 mg
Subject trimethoprim-sulfamethoxazole Unknown 8 mg/kg
Subject trimethoprim-sulfamethoxazole Unknown 160 mg